Literature DB >> 14440555

Reoviruses. A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described.

A B SABIN.   

Abstract

Keywords:  VIRUSES

Mesh:

Year:  1959        PMID: 14440555     DOI: 10.1126/science.130.3386.1387

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  119 in total

1.  Reovirus as a novel oncolytic agent.

Authors:  K L Norman; P W Lee
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

2.  Myocarditis associated with reovirus infection.

Authors:  F Terheggen; E Benedikz; P H J Frissen; K Brinkman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-01       Impact factor: 3.267

3.  Antigenic purity and plaque properties of the prototype strains of ECHO virus types 7 to 11, and 17 and 18.

Authors:  R WIGAND; A B SABIN
Journal:  Arch Gesamte Virusforsch       Date:  1962

4.  VIRAL RESPIRATORY TRACT ILLNESSES IN CHILDREN.

Authors:  R H PARROTT
Journal:  Bull N Y Acad Med       Date:  1963-10

5.  ISOLATION OF A REOVIRUS FROM A CASE OF BURKITT'S LYMPHOMA.

Authors:  T M BELL; A MASSIE; M G ROSS; M C WILLIAMS
Journal:  Br Med J       Date:  1964-05-09

6.  ANIMAL AND PLANT VIRUSES WITH DOUBLE-HELICAL RNA.

Authors:  P J GOMATOS; I TAMM
Journal:  Proc Natl Acad Sci U S A       Date:  1963-11       Impact factor: 11.205

7.  ASSOCIATION BETWEEN THE SPINDLE APPARATUS AND REOVIRUS.

Authors:  S DALES
Journal:  Proc Natl Acad Sci U S A       Date:  1963-08       Impact factor: 11.205

8.  MURINE INFECTION WITH REOVIRUS: I. PATHOLOGY OF THE ACUTE PHASE.

Authors:  M N WALTERS; R A JOSKE; P J LEAK; N F STANLEY
Journal:  Br J Exp Pathol       Date:  1963-08

Review 9.  SUBCLASSIFICATION OF PICORNAVIRUSES.

Authors:  L ROSEN
Journal:  Bacteriol Rev       Date:  1965-06

Review 10.  Reovirus: a targeted therapeutic--progress and potential.

Authors:  Radhashree Maitra; Mohammad H Ghalib; Sanjay Goel
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.